SEC ownership of NUTRA PHARMA CORP

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001119643.

Comparable stake leader

Pure Raw Supplies, LLC

Disclosed value leader

—

Comparable rows

1/2

Latest evidence

21 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
1 of 2
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Pure Raw Supplies, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
21 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001119643
Issuer location
Boca Raton, FL

Ownership snapshot

Top shareholders of NUTRA PHARMA CORP (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Pure Raw Supplies, LLC
Disclosed value leader
—
Comparable rows
1/2
Latest evidence
21 Aug 2026
3/4/5 13D/G Lead comparable stake: 100% 1 rows are not safely comparable across share classes. 13D/G row: Pure Raw Supplies, LLC

Quick read

Pure Raw Supplies, LLC leads the comparable SEC ownership view at 100%.

1 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pure Raw Supplies, LLC's linked filing trail.
Comparable ownership Top 1
Pure Raw Supplies, LLC 100%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-2 of 2 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Pure Raw Supplies, LLC
3/4/5 13D/G
10%+ Owner
100%
Reported 13D/G · 21 Aug 2026
—
12,000,000 shares
— 21 Aug 2026
Rik J. Deitsch
3/4/5
10%+ Owner
—
denominator unverified
—
43,298,859 shares
— 21 Aug 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 22 Oct 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-2 of 2 reporting-owner rows connected to NUTRA PHARMA CORP. Open a relationship link for the CIK-to-CIK filing trail.

Rows
2
Largest Forms 3/4/5 holder
Rik J. Deitsch
Net 12M change
$0
Latest report
21 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Rik J. Deitsch 10%+ Owner Mixed 21 Aug 2026
Pure Raw Supplies, LLC 10%+ Owner Mixed 21 Aug 2026

Recent insider transactions for NUTRA PHARMA CORP

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Rik J. Deitsch NPHC Series B Preferred Stock Gift -100% -12,000,000 0 21 Aug 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .